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1 Editor, SEEd Medical Publishers
According to the Budapest Open Access Initiative, open access means «immediate, free availability on 
the public internet, permitting any users to read, download, copy, distribute, print, search or link to the 
full text of these articles, crawl them for indexing, pass them as data to software or use them for any 
other lawful purpose».
Health care literature dissemination is part of the core mission of Reviews in Health Care. That’s why, 
since its launch in October 2010, Reviews in Health Care has been willing to develop an open access 
model. 
We are now very pleased to announce to our authors and readers that every article published in the 
journal is freely accessible on the Web, immediately on publication. 
To this purpose, we developed a new website (http://journals.edizioniseed.it/index.php/rhc, based on 
the Open Journal Systems journal management) where all the articles are freely available in html (a 
registration is required). 
We believe that, at a time of tight research budgets, it is not reasonable to expect Universities or au-
thors to pay thousands of dollars to publish an article. Therefore, Reviews in Health Care offers the au-
thors the opportunity to publish their papers at no cost. All the articles can be submitted online, then 
are submitted to the peer-review process. Final manuscripts of all accepted articles are also deposited 
into DOAJ (Directory of Open Access Journals), thus increasing their visibility and ease of use. In 
addition, RHC permits and encourages authors to post items submitted to the journal on personal 
websites or institutional repositories both prior to and after publication, providing adequate credits 
to the journal.
We hope that this choice is appreciated by authors and readers. We also hope we can have a part (even 
if small) in broadening the circulation and exchange of knowledge, not only in academic institutions, 
but also to all the interested professionals, to concerned journalists and policymakers.
What follows is a short interview with Peter Suber, an independent policy strategist for open access to 
research. More information about OA can be found at http://www.sherpa.ac.uk/links.html. 
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Interview with Peter Suber
Peter Suber (http://bit.ly/suber) is Berkman Fellow at Harvard University, Senior Researcher at SPARC, 
the Open Access Project Director at Public Knowledge, and Research Professor of Philosophy at Earlham 
College. He conducts research, writing, consulting, and advocacy on open access and related topics.
Q: The aim of open access is to remove access barriers to publication. Don’t you think that fee-
based model can be an obstacle for authors in less-developed countries?
A: Fee-based OA journals don’t work as well as no-fee OA journals in fields and countries where most 
research is unfunded. But it’s important to remember that the vast majority of OA journals (70%) 
charge no publication fees at all. The percentage is even higher for OA journals published in developing 
countries. For example, nearly all the OA journals published in India are no-fee. It’s equally important 
to remember that green OA, or OA through repositories, is an inexpensive alternative to gold OA, or 
OA through journals. More often than not, authors who publish in subscription-based journals have 
standing permission from the publisher to deposit their peer-reviewed manuscript in an OA reposi-
tory. The percentage can approach 100% when universities and funding agencies require faculty and 
grantees to retain the right to authorize OA. For example, 100% of surveyed publishers accommodate 
the green OA mandate at the US National Institutes of Health.
Q: OA is compatible with peer review. Do you think that new approaches to peer review, such as 
open peer review, could arise from the OA movement?
A: OA is compatible with every kind of peer review, and does not presuppose or favor any particular 
kind. However, some new kinds of peer review, such as open review, presuppose OA. I welcome these 
experiments. But whether or not open review can be made to work, I hope that editors learn from 
the experiments. The OA movement is committed to the survival and integrity of peer review, but it’s 
agnostic about the best from of peer review.
Q: In discussion about OA is usually stressed the role of Libraries and Institutions. What could be, 
in your opinion, the role of private publishers in this movement (if they have one)?
A: Publishers will always have a role in OA, if they want one. They can publish peer-reviewed OA 
journals, so-called gold OA, or they can allow authors to deposit their peer-reviewed manuscripts in 
OA repositories, so-called green OA. The OA 
movement does not oppose publishers or publi-
shing, only access barriers. Moreover, publi-
shers themselves are not monolithic. Some pro-
vide OA themselves. Some – in fact, a majority 
– allow their authors to provide OA at will, and 
a growing number of others are experimenting 
with OA. OA has everything to gain and no-
thing to lose working with publishers who cho-
ose to work with OA.
We welcome your comments
Reviews in Health Care welcomes your Let-
ters to the Editor about editorials and arti-
cles that appear in RHC or issues relevant 
to healthcare. Address correspondence to 
s.maina@edizioniseed.it or submit your let-
ter online at http://journals.edizioniseed.it/
index.php/rhc.
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Featured in this issue
Bacterial infections in patients with liver cirrhosis
Medical area. •  Infectivology; Hepathology.
Why is a review on this topic needed? •  Bacterial infections represent a frequent complication of 
liver cirrhosis carrying a significantly greater risk of morbidity and mortality as compared to that 
observed in non-cirrhotic patients.
Key message. •  The severity of liver disease represents the major clinical factor predisposing to bac-
terial infections, which are asymptomatic or paucisymptomatic at presentation in almost half of the 
cases. Beside antibiotics, it has been proposed the administration of human albumin to prevent the 
development of renal failure in patients with spontaneous bacterial peritonitis and, more recently, 
the use of hydrocortisone to treat cirrhotic patients with septic shock.
Peripartum cardiomyopathy
Medical area. •  Gynaecology; Cardiology.
Why is a review on this topic needed? •  The early diagnosis of peripartum cardiomyopathy and the 
institution of medical treatment for this disease are essential to avoid severe complications, inclu-
ding death. Nonetheless, currently its aetiology is not completely understood.
Key message. •  Prolactin and its 16 kDa metabolite seem to have a role in reducing cardiomyocite 
metabolic activity and contraction.
Exercise stress testing in clinical practice
Medical area. •  Cardiology.
Why is a review on this topic needed? •  Exercise stress testing is an important diagnostic tool for 
evaluating patient’s cardiovascular performance.
Key message. •  Exercise stress testing has an improved accuracy and is more clinically relevant when 
multiple risk parameters (ST-segment deviation, chest pain, exercise time, chronotropic competen-
ce, heart rate recovery, blood pressure recovery, ventricular arrhythmias) are incorporated into the 
final test result evaluation.
The public health sector supply of modern contraceptives in rural Nigeria: an 
analysis of selection, forecasting and inventory control
Medical area. •  Public health; Contraception.
Why is a review on this topic needed? •  Since public health facilities in rural Nigeria have been 
experiencing a long period of stock-outs and unavailability of modern contraceptives, recommen-
dations are needed on how to improve the supply of modern contraceptives in this area.
Key message. •  The current essential drug list should be reviewed in order to include injectables for 
use in primary facilities, strengthen the current forecasting, data reporting and inventory control 
system.
